Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 8, 2026, 9:30 AM EST

Endonovo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
031027
Market Cap Growth
49.80%211.36%127.79%-74.11%-74.55%-57.10%
Enterprise Value
-11871115
Last Close Price
0.000.020.020.021.9018.20

Price Ratios

Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
PS Ratio
0.7125.8415.372.986.1489.88
PB Ratio
-0.01-0.11-0.07-0.03-0.09-0.66

EV Ratios

Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
EV/Sales Ratio
-79.16107.9239.7434.81182.79

Financial Efficiency

Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Debt / Equity Ratio
-0.31-0.22-0.45-0.46-0.42-0.69
Net Debt / Equity Ratio
-0.31-0.22-0.45-0.46-0.42-0.66
Net Debt / EBITDA Ratio
-3.58-2.73-4.50-2.93-2.74-2.13
Net Debt / FCF Ratio
-11.20-10.54-7.19-8.93-3.40-2.59
Asset Turnover
0.230.080.030.060.080.02
Quick Ratio
-00.010.000.000.03
Current Ratio
0.0000.010.000.000.03
Return on Assets (ROA)
-144.27%-124.08%-60.32%-61.89%-63.34%-58.72%
Return on Capital Employed (ROCE)
11.40%10.20%14.20%20.50%18.70%37.00%

Yields

Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Earnings Yield
-2436.51%-528.17%-276.38%-80.21%-908.97%-86.00%
FCF Yield
-348.48%-19.41%-87.82%-150.37%-133.53%-38.59%
Buyback Yield / Dilution
-130.88%-132.64%-389.83%-1651.87%-92.38%-49.72%